Loading clinical trials...
Loading clinical trials...
Patients with COPD lose muscle strength during acute exacerbations of COPD (AECOPD) which interferes improving the recovery of physical activity (PA) after an AECOPD. Resistance training can reverse this process. An exercise training program with the focus on resistance training is essential in minimizing the long-term effects of AECOPD as it may help to accelerate the gain in PA in the weeks after an acute event. Therefore, it is important that such programs are embedded at the right moment (i.e. immediately after an AECOPD) and in a setting accessible to the patient (i.e. primary care). The efficacy and effectiveness of implementing such training programs will be assessed in the present study.
The present study aims to: 1. Investigate whether an 8 week exercise training program provided in primary or community care enhances lower limb muscle strength in patients following an AECOPD; 2. Investigate whether such programs assist patients after an AECOPD to re-engage with a coaching intervention geared to long-term PA maintenance or improvement. The secondary aim is to investigate how (repeated) AECOPD contribute to structural alterations in the skeletal muscle and how an exercise training program and PA can influence the deterioration in muscle fiber morphology and signals related to muscle atrophy. Patients that experience a moderate or severe AECOPD will be recruited in the present multicentre randomised controlled trial (RCT). Patients in this study will have at least 3 clinical visits: * Post AECOPD treatment: screening and randomisation visit (V1) * 8 weeks after randomisation (V2a and V2b\*) * 52 weeks after randomisation (V3a and V3b\*) * If patients agree to have a muscle biopsy taken, a V2b and V3b will be added, so this does not interfere with other measurements. These visits will take place 1-2 weeks after V2a and V3a, respectively. After the screening and randomisation visit (V1), the patient will be randomised in either the intervention group (PA coaching and exercise training) or the control group (PA coaching). Patients in the intervention group will receive a first physiotherapy session during this first visit provided by the trained researchers (with a degree in physiotherapy) to get acquainted with the exercises. Information about the PA coaching will be given to all the patients. The intervention will be started after this visit and is provided by a physiotherapist in primary or community care.
Age
40 - No limit years
Sex
ALL
Healthy Volunteers
No
UZ Gent
Ghent, Belgium
University Hospitals Leuven
Leuven, Belgium
Start Date
February 8, 2022
Primary Completion Date
January 14, 2025
Completion Date
January 14, 2025
Last Updated
June 19, 2025
86
ACTUAL participants
PA coaching
BEHAVIORAL
Exercise training
OTHER
Lead Sponsor
KU Leuven
Collaborators
NCT07351929
NCT05958563
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06347536